Apricus Wealth
PFE icon

Apricus Wealth’s Pfizer PFE Stock Holding History

Apricus Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$225K Sell
7,879
-3,275
-29% -$87.1K 0.1% 116
2026
Q2 		$269K Sell
11,154
-113,108
-91% -$2.96M 0.13% 108
2026
Q1 		$3.49M Buy
124,262
+4,584
+4% +$122K 1.7% 27
2025
Q4 		$2.98M Buy
119,678
+15,660
+15% +$395K 1.52% 32
2025
Q3 		$2.65M Sell
104,018
-3,220
-3% -$79.5K 1.43% 38
2025
Q2 		$2.6M Sell
107,238
-3,553
-3% -$82.9K 1.51% 34
2025
Q1 		$2.81M Buy
110,791
+20,406
+23% +$534K 1.67% 26
2024
Q4 		$2.4M Sell
90,385
-14,585
-14% -$396K 1.56% 27
2024
Q3 		$3.04M Buy
104,970
+4,200
+4% +$123K 2% 17
2024
Q2 		$2.82M Buy
100,770
+6,563
+7% +$181K 2.01% 17
2024
Q1 		$2.61M Buy
94,207
+24,331
+35% +$675K 1.84% 25
2023
Q4 		$2.01M Buy
69,876
+11,689
+20% +$353K 1.53% 32
2023
Q3 		$1.87M Buy
58,187
+11,625
+25% +$411K 1.63% 28
2023
Q2 		$1.67M Buy
46,562
+495
+1% +$19.3K 1.47% 33
2023
Q1 		$1.88M Buy
46,067
+3,020
+7% +$130K 1.71% 28
2022
Q4 		$2.21M Sell
43,047
-720
-2% -$34.5K 2.01% 24
2022
Q3 		$1.92M Sell
43,767
-4,035
-8% -$196K 1.9% 23
2022
Q2 		$2.51M Buy
47,802
+2,025
+4% +$103K 2.29% 17
2022
Q1 		$2.28M Buy
45,777
+1,090
+2% +$56.6K 1.86% 22
2021
Q4 		$2.64M Buy
+44,687
New +$2.21M 2.35% 13

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Apricus Wealth's PFE Position: Q3 2026 in Review

Apricus Wealth reduced its Pfizer (PFE) stake by 29% in Q3 2026, selling an estimated $87.1K and leaving 7,879 shares worth $225K. The position accounts for 0.1% of the portfolio, ranked #116.

Apricus Wealth first reported a position in PFE in Q4 2021 and has held it in 20 quarters since. The position peaked at $3.49M in Q1 2026. 1,268 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Apricus Wealth held 7,879 shares of Pfizer worth $225K as of Q3 2026.
  • Apricus Wealth sold 3,275 Pfizer shares in Q3 2026, an estimated $87.1K.
  • Pfizer made up 0.1% of Apricus Wealth's portfolio in Q3 2026, its #116 holding.
  • Apricus Wealth first reported a position in Pfizer in Q4 2021 and has held it in 20 quarters since.
  • Apricus Wealth's Pfizer position peaked at $3.49M in Q1 2026.
  • 1,268 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Apricus Wealth's 13F filing for Q3 2026, filed 26 Oct 2026.